Image_1_RW-BP100-4D, a Promising Antimicrobial Candidate With Broad-Spectrum Bactericidal Activity.TIF
With the rapid emergence and dissemination of antimicrobial resistance (AMR) genes in bacteria from animal, animal-derived food and human clinic, it is of great significance to develop new approaches to combat the multidrug-resistant bacteria. This study presented a short linear antimicrobial peptide RW-BP100-4D, which was derived from RW-BP100 (RRLFRRILRWL-NH2) by transforming the N-terminal 4th amino acid from L- to D-enantiomer. This modification remarkably reduced the peptide cytotoxicity to mammalian cells, as indicated by hemolytic and cytotoxicity assays. Meanwhile, the antimicrobial activity of RW-BP100-4D was improved against a more variety of Gram-positive and Gram-negative bacteria (sensitive and resistant) as well as fungi. Also, RW-BP100-4D showed strong in vitro anti-biofilm activity in a concentration-dependent manner, including inhibition of the biofilm-formation and dispersion of the mature biofilms of Staphylococcus aureus. RW-BP100-4D could be efficiently uptaken by bovine mammary epithelial cells (MAC-T) cells to eliminate the intracellular S. aureus ATCC29213 and Salmonella enterica ATCC13076. Moreover, RW-BP100-4D was highly effective in food disinfection of multiple bacterial contamination (including S. aureus, Listeria monocytogenesis, Escherichia coli O157: H7, Campylobacter jejuni, S. enterica, and Shewanella putrefaction, 3.61 ± 0.063 log reduction) on chicken meat, and could kill 99.99% of the methicillin-resistant Staphylococcus aureus (MRSA) strain in the mouse skin infection model. In summary, RW-BP100-4D is a promising antimicrobial candidate for application on food disinfection and local infection treatment. However, the protease-sensitivity of RW-BP100-4D and toxic effect at higher doses reduced the therapeutic effect of the candidate peptide in vivo and should be improved in the future studies.
History
References
- https://doi.org//10.1177/0022034516679973
- https://doi.org//10.1128/AAC.00208-07
- https://doi.org//10.1038/nrmicro1098
- https://doi.org//10.1007/s00253-016-7621-6
- https://doi.org//10.1177/039139880703000903
- https://doi.org//10.1016/j.bpj.2008.11.053
- https://doi.org//10.1371/journal.pone.0009098
- https://doi.org//10.1080/10408398.2013.763765
- https://doi.org//10.1128/AEM.02759-10
- https://doi.org//10.1093/jac/dkz339
- https://doi.org//10.1089/wound.2014.0538
- https://doi.org//10.1186/1556-276X-6-480
- https://doi.org//10.1007/s12275-011-1013-5
- https://doi.org//10.1371/journal.pmed.1001921
- https://doi.org//10.3390/molecules24203727
- https://doi.org//10.1038/s42003-020-01511-1
- https://doi.org//10.1016/j.bbamem.2009.04.021
- https://doi.org//10.1007/s00018-011-0718-2
- https://doi.org//10.1097/00001813-200102000-00003
- https://doi.org//10.1073/pnas.1221924110
- https://doi.org//10.1111/j.1574-6968.2007.00683.x
- https://doi.org//10.1007/978-1-4939-9167-9_12
- https://doi.org//10.3109/07388551.2011.594423
- https://doi.org//10.1016/0006-2952(78)90370-2
- https://doi.org//10.1158/0008-5472.CAN-04-2086
- https://doi.org//10.1016/j.ejpb.2004.07.008
- https://doi.org//10.1094/MPMI-19-0699
- https://doi.org//10.1038/s41564-020-0723-z
- https://doi.org//10.1089/mdr.2019.0062
- https://doi.org//10.1002/bip.20286
- https://doi.org//10.1016/j.bbamem.2012.12.002
- https://doi.org//10.1124/pr.55.1.2
- https://doi.org//10.1016/j.bbamem.2016.03.014
- https://doi.org//10.1038/415389a
- https://doi.org//10.1186/s40779-021-00343-2
CC BY 4.0